HIV lipodystrophy: where are we after ten years?
Vergel
Nelson
N
D019380:Anti-HIV Agents / Q000009:adverse effects; D039682:HIV-Associated Lipodystrophy Syndrome / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans
D019380:Anti-HIV Agents